From: Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort
No dyspnea (n = 41) | Dyspnea (n = 35) | |
---|---|---|
Demographics | ||
Age | 60 ± 16 | 63 ± 16 |
Male | 27 (66) | 20 (57) |
Ever smoker | 10 (25) | 13 (37) |
Comorbidities | ||
Cardiac | 4 (10) | 10 (29) |
Pulmonary | 6 (15) | 10 (29) |
Renal | 2 (5) | 5 (14) |
Diabetes | 11 (27) | 7 (20) |
Hypertension | 15 (37) | 11 (31) |
Dyslipidemia | 12 (29) | 12 (34) |
Malignancy | 4 (10) | 4 (11) |
COVID-19 infection characteristics | ||
Admission to hospital | 40 (98) | 34 (97) |
Length of admission in days | 6.5 (5–11) | 11 (5–17) |
Length of oxygen requirements in days | 5 (3–11) | 11 (7–19) |
ICU/HAU admission | 19 (46) | 17 (49) |
Mechanical ventilation | 7 (17) | 6 (17) |